Cardio Diagnostics

The company's solutions:

The only blood test-of-its-kind (Epi+Gen CHD) in the world to offer personalized (epigenetics-based) insights into coronary heart disease drivers and assess the risk of a heart attack in the next three years. This risk assessment test evaluates five single nucleotide polymorphisms (SNPs) and three DNA methylation markers in genomic DNA isolated from human peripheral whole blood specimens.

The only blood test-of-its-kind in the world (PrecisionCHD) to detect the presence of coronary heart disease (epigenetics-based).
Both tests are accompanied by Actionable Clinical Intelligence (a personalized report about specific drivers of coronary heart disease) and HeartRisk which is an Employer CVD Risk Intelligence platform (an employer-specific dashboard reviewing population health CVD statistics in their industry along with aggregated employee CHD risk insights to better allocate benefits resources).